Loading clinical trials...

An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST) | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00618319

An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)

This study will examine the effect of BIIB021 on GIST growth and metabolism.

Lead sponsor: Biogen•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Familial Investigations of Childhood Cancer Predisposition

NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more

RECRUITINGPhase 1/2

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

NCT05957367 · GIST

RECRUITINGPhase 1

A Study of HQP1351 in Patients With GIST or Other Solid Tumors

NCT03594422 · Gastrointestinal Stromal Tumor (GIST), Solid Tumor, Adult

RECRUITINGNA

RCT of EFTR Versus STER for GIST Treatment

NCT07411118 · Small Size Gastrointestinal Stromal Tumors, GIST

RECRUITINGPhase 1

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

NCT06655246 · Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Stromal Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 2, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment20

Start dateFeb 2008

Last updatedOct 2, 2015

Condition

GIST

Locations shown

Reseach Facility

Encinitas, California

Research Site

Santa Monica, California

Reseach Facility

San Antonio, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 2, 2015Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions